The subsequent step involved evaluating whether BIRC5, FGF1, RASSF6, SERPINE1 and STK4 could serve as targets for miRNAs differentiating breast cancer from the control (Table 5). This evidence concerns the gene SERPINE1 and breast carcinoma.